Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance
Abstract Ferroptosis, the non-apoptotic, iron-dependent form of cell death is an unavoidable outcome and byproduct of cellular metabolism. Reactive oxygen species generation during metabolic activities transcends to Fe2+-induced lipid peroxidation, leading to ferroptosis. Cancer cells being highly m...
Saved in:
| Main Authors: | Sramana Bhowmick, Saptak Banerjee, Viji Shridhar, Susmita Mondal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Molecular Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12943-025-02337-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets
by: Zhiyang Yin, et al.
Published: (2025-04-01) -
Ferroptosis in osteoarthritis: metabolic reprogramming, immunometabolic crosstalk, and targeted intervention strategies
by: Shenglin Xia, et al.
Published: (2025-06-01) -
Exploring the significance of fatty acid metabolism reprogramming in the pathogenesis of cancer and anticancer therapy
by: Jiaao Sun, et al.
Published: (2025-12-01) -
Dexmedetomidine Ameliorates Myocardial Ischemia‐Reperfusion Injury by Inhibiting MDH2 Lactylation via Regulating Metabolic Reprogramming
by: Han She, et al.
Published: (2024-12-01) -
Self-healable and pH-responsive spermidine/ferrous ion complexed hydrogel Co-loaded with CA inhibitor and glucose oxidase for combined cancer immunotherapy through triple ferroptosis mechanism
by: Tianqi Nie, et al.
Published: (2025-05-01)